To determine whether Rab11b plays a causal role in breast cancer brain metastasis formation, we used two shRNA constructs targeting Rab11b and confirmed that they decrease Rab11b mRNA and protein (Fig. 3a, b, Supplementary Fig. 4a, b), as well as active Rab11b (Fig. 3c). Here, RAB11B is linked to breast cancer.